Nanoparticulate carriers (NPC) for oral pharmaceutics and nutraceutics

Pharmazie

Volumn 65, Issue 2, 2010, Pages 75-82

  Lopes, C M ^a,b   Martins Lopes, P ^b   Souto, Eliana B ^a,b  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ARGIPRESSIN; CHITOSAN; DNA; GAMMA INTERFERON; GELATIN; GLUTARALDEHYDE; LIPOSOME; MACROGOL; MICROSPHERE; NANOCARRIER; NANOSPHERE; NUTRACEUTICAL; OLIGONUCLEOTIDE; PEPTIDE; PHOSPHOLIPID; POLOXAMER; POLOXAMINE 908; POLY(ORTHO ESTER); POLYAMINE; POLYANHYDRIDE; POLYCAPROLACTONE; POLYESTER; POLYGLACTIN; POLYMER; POLYSACCHARIDE; PROTEIN; UNINDEXED DRUG; VACCINE; WATER OIL CREAM;

BIOCOMPATIBILITY; BIODEGRADABILITY; DRUG ABSORPTION; DRUG COATING; DRUG DISTRIBUTION; DRUG ELIMINATION; GELATION; PARTICLE SIZE; POLYMERIZATION; REVIEW; SURFACE PROPERTY; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ALBUMINS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIETARY SUPPLEMENTS; DRUG CARRIERS; EXCIPIENTS; GELATIN; HUMANS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; POLYMERS; POLYSACCHARIDES;

EID: 76149110101     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9338     Document Type: Review

References (141)

1. Ahmad Z, Pandey R, Sharma S, Khuller GK (2006) Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Indian J Chest Dis Allied Sci 48: 171-176.
2. Akiyoshi K, Deguchi S, Tajima H, Nishikawa T, Sunamoto J (1997) Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromolecules 30: 857-861.
3. Akiyoshi K, Kang EC, Kurumada S, Sunamoto J, Principi T, Winnik FM (2000) Controlled association od amphiphilic polymers in water: thermosensitive nanoparticles formed by self-assembly of hydrophobically modified pullulans and poly(N-isopropyllacrylamide). Macromolecules 33: 3244-3249.
4. Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J (2006) Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul 23: 582-592.
5. Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W(2006) Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 111: 107-116.
6. Ankola DD,Viswanad B, Bhardwaj V, Ramarao P,Kumar MN (2007) Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Eur J Pharm Biopharm 67: 361-369.
7. Arbos P, Arangoa MA, Campanero MA, Irache JM (2002) Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int J Pharm 242: 129-136.
8. Arnedo A, Irache JM, Merodio M, Espuelas Millan MS (2004) Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide. J Control Release 94: 217-227.
9. Artursson P, Lindmark T, Davis SS, Illum L (1994) Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial-Cells (Caco-2). Pharm Res 11: 1358-1361.
10. Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K (2005) Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 26: 2723-2732.
11. Baran ET, Ozer N, Hasirci V (2002) In vivo half life of nanoencapsulated L-asparaginase. J Mater Sci Mater Med 13: 1113-1121.
12. Bayat A, Larijani B, Ahmadian S, Junginger HE, Rafiee-Tehrani M (2008) Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomedicine 4: 115-120.
13. Bell LN (2001) Stability testing of nutraceuticals and functional food. In: R.E. C Wildman (Ed.), Handbook of nutraceuticals and functional food. New York: CRC Press: 501-516.
14. Bertholon I, Vauthier C, Labarre D (2006) Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23: 1313-1323.
15. Bhadra D, Bhadra S, Jain P, Jain NK (2002) Pegnology: a review of PEG-ylated systems. Pharmazie 57: 5-29.
16. Bhattarai N, Ramay HR, Chou S-H, Zhang M (2006) Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int J Nanomed 1: 181-187.
17. Blummel J, Perschmann N, Aydin D, Drinjakovic J, Surrey T, Lopez-Garcia M, Kessler H, Spatz JP (2007) Protein repellent properties of covalently attached PEG coatings on nanostructured SiO(2)-based interfaces. Biomaterials 28: 4739-4747.
18. Bodnar M, Hartmann JF, Borbely J (2005) Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6: 2521-2527.
19. Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, Borchard G, Junginger HE (2006) Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release 114: 348-358.
20. Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-SilvaA(2007) Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. Eur J Pharm Sci 32: 278-290.
21. Bowman K, Leong KW (2006) Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomed 1: 117-128.
22. Cascone MG, Lazzeri L, Carmignani C, Zhu Z (2002) Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med 13: 523-526.
23. Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, Aitken R, Watkins R (2008) Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25: 241-258.
24. Chauvierre C, Labarre D, Couvreur P, Vauthier C (2003) Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharm Res 20: 1786-1793.
25. Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y (2008) In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 349: 226-233.
26. Chen LY, Remondetto GE, SubiradeM(2006) Food protein-based materials as nutraceutical delivery systems. Trends Food Sci Technol 17: 272-283.
27. Chen LY, Subirade M (2005) Chitosan/beta-lactoglobulin core-shell nanoparticles as nutraceutical carriers. Biomaterials 26: 6041-6053.
28. Choi SH, Lee JH, Choi SM, Park TG (2006) Thermally reversible pluronic/heparin nanocapsules exhibiting 1000-fold volume transition. Langmuir 22: 1758-1762.
29. Clark MA, Jepson MA, Hirst BH (2001) Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 50: 81-106.
30. Coester C, Kreuter J, von Briesen H, Langer K (2000) Preparation of avidinlabelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA). Int J Pharm 196: 147-149.
31. Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C (2002) Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst 19: 99-134.
32. Couvreur P, Dubernet C, Puisieux F (1995) Controlled Drug-Delivery with Nanoparticles-Current Possibilities and Future-Trends. Eur J Pharm Biopharm 41: 2-13.
33. De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles:applications and hazards. Int J Nanomed 3: 133-149.
34. des Rieux A, Fievez V, Garinot M, Schneider Y-J, Preat V (2006a) Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 116: 1-27.
35. Desai MP, Labhasetwar V, Amidon GL, Levy RJ (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13: 1838-1845.
36. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL (1997) The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 14: 1568-1573.
37. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discov 2: 347-360.
38. Elliott R, Ong TJ (2002) Science, medicine, and the future-Nutritional genomics. Br Med J 324: 1438-1442.
39. Florence AT (2005) Nanoparticle uptake by the oral route: Fulfilling its potential? Drug Discov Tod: Technologies 2: 75-81.
40. Galindo-Rodriguez SA, Allémann E, Fassi H, Doelker E (2005) Polymeric nanoparticles for oral delivery of drugs and vacines: A critical evaluation of in vivo studies. Crit Rev Ther Drug Car Sys 22: 419-463.
41. Garcia-Fuentes M, Torres D, Alonso MJ (2005) New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm 296: 122-132.
42. Gayathri VP (2003) Biopolymer albumin for diagnosis and in drug delivery. Drug Development Research 58: 219-247.
43. Goldie K, Mansoor A (2005) Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies. Pharm Res 22: 951-961.
44. Goldstein IJ, Hughes RC, Monsigny M, Osawa T, Sharon N (1980) What should be called lectin? Nature 285: 1438-1442.
45. Goppert TM, Muller RH (2005) Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int J Pharm 302: 172-186.
46. Gref R (2002) Surface engineered nanoparticles as drug carriers. In: Baraton, MT, Editor. Synthesis, functionalization and surface treatment of nanoparticles. American Scientific Publishers: 233-256.
47. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263: 1600-1603.
48. Gref R, Rodrigues J, Couvreur J (2002) Polysaccharides grafted with polyester: novel amphiphilic copolymers for biomedical application Macromolecules 35: 9861-9867.
49. Groziak SM, Miller GD (2000) Natural bioactive substances in milk and colostrum: effects on the arterial blood pressure system. Br J Nutr 84 (Suppl 1): S119-125.
50. Hamman JH, Enslin GM, Kotze AF (2005) Oral delivery of peptide drugs: barriers and developments. BioDrugs 19: 165-177.
51. Han SK, Lee JH, Kim D, Cho SH, Yuk SH (2005) Hydrophilized poly(lactide-co-glycolide) nanoparticles with core/shell structure for protein delivery. Sci Technol Adv Mat 6: 468-474.
52. Hirano S (1996) Chitin biotechnology applications. Biotechnol Annu Rev 2: 237-258.
53. Hussain N, JaitleyV, FlorenceAT (2001) Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50: 107-142.
54. Jain D, Banerjee R (2008) Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater 86: 105-112.
55. Jain RA (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490.
56. Janes KA, Calvo P, Alonso MJ (2001) Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 47: 83-97.
57. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 73: 255-267.
58. Jang KI, Lee HG (2008) Stability of chitosan nanoparticles for L-ascorbic acid during heat treatment in aqueous solution. J Agric Food Chem 56: 1936-1941.
59. Jensen H, Bremholm M, Nielsen RP, Joensen KD, Pedersen JS, Birkedal H, Chen YS, Almer J, Sogaard EG, Iversen SB, Iversen BB (2007) In situ high-energy synchrotron radiation study of sol-gel nanoparticle formation in supercritical fluids. Angew Chem Int Ed Engl 46: 1113-1116.
60. Jeong YI, Kim SH, Jung TY,Kim IY, Kang SS, Jin YH, Ryu HH, Sun HS, Jin S, Kim KK, Ahn KY, Jung S (2006) Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. J Pharm Sci 95: 2348-2360.
61. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T (2000) Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 50: 147-160.
62. Kaul G, Amiji M (2005) Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. J Pharm Sci 94: 184-198.
63. Kawashim Y (2001) Nanoparticulate system for improved drug delivery. Adv Drug Deliv Rev 47: 1-2.
64. Kipp JE (2004) The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 284: 109-122.
65. Kommareddy S, Amiji M (2005) Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconj Chem 16: 1423-1432.
66. Kommareddy S, Tiwari SB, Amiji MM (2005) Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol Cancer Res Treat 4: 615-625.
67. Kreuter J (1994) Drug Targeting with Nanoparticles. Eur J Drug Met Pharm 19: 253-256.
68. Kreuter J, Gelperina S (2008) Use of nanoparticles for cerebral cancer. Tumori 94: 271-277.
69. Kuroda K, Fujimoto K, Sunamotto J (2002) Hierarchical self-assembly of hydrophobically modified pullulan in water: gelation by networks of nanoparticles. Langmuir 18: 3244-3249.
70. Labarre D, Vauthier C, Chauvierre C, Petri B, Muller R, Chehimi MM (2005) Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26: 5075-5084.
71. Lalush I, Bar H, Zakaria I, Eichler S, Shimoni E (2005) Utilization of amylose-lipid complexes as molecular nanocapsules for conjugated linoleic Acid. Biomacromolecules 6: 121-130.
72. Lamprecht A, Saumet JL, Roux J, Benoit JP (2004) Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 278: 407-414.
73. Langer R (2000) Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 33: 94-101.
74. Lee CH, Jung KY, Choi JG, Kang YC (2005) Nano-sizedY(2)O(3): Eu phosphor particles prepared by spray pyrolysis. Mat Sc Engineering B: Sol State Mat Adv Technol 116: 59-63.
75. Lee CH, Singla A, Lee Y (2001) Biomedical applications of collagen. Int J Pharm 221: 1-22.
76. Lee JW, Park JH, Robinson JR (2000) Bioadhesive-based dosage forms: the next generation. J Pharm Sci 89: 850-866.
77. Lee PW, Peng SF, Su CJ, Mi FL, Chen HL, Wei MC, Lin HJ, Sung HW (2008) The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermalDNAdelivery. Biomaterials 29: 742-751.
78. Lemarchand C, Couvreur P, Besnard M, Costantini D, Gref R (2003) Novel polyester-polysaccharide nanoparticles. Pharm Res 20: 1284-1292.
79. Lemarchand C, Gref R, Couvreur P (2004) Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 58: 327-341.
80. Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P (1996) Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials 17: 2191-2197.
81. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT (1998) DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 53: 183-193.
82. Li JK, Wang N, Wu XS (1997) A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. J Pharm Sci 86: 891-895.
83. Li JK, Wang N, Wu XS (1998) Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method. J Microencapsul 15: 163-172.
84. Li YY, Chen XG, Liu CS, Cha DS, Park HJ, Lee CM (2007) Effect of the molecular mass and degree of substitution of oleoylchitosan on the structure, rheological properties, and formation of nanoparticles. J Agr Food Chem 55: 4842-4847.
85. Linhardt RJ (1989) Biodegradable polymers for controlled release of drugs. In Controlled Release of Drugs. M Rosoff, Editor, VCH Publishers: New York: 53-95.
86. Listinsky JJ, Siegal GP, Listinsky CM (1998) Alpha-L-fucose: a potentially critical molecule in pathologic processes including neoplasia. Am J Clin Pathol 110: 425-440.
87. Liu H, Chen B, Mao Z, Gao CY (2007) Chitosan nanoparticles for loading of toothpaste actives and adhesion on tooth analogs. J Appl Polym Sci 106: 4248-4256.
88. Liu Z, Jiao Y, Liu F, Zhang Z (2007) Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation. J Biomed Mater Res A 83: 806-812.
89. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60: 1650-1662.
90. Lu B, Xiong SB, Yang H, Yin XD, Zhao RB (2006) Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization. Int J Pharm 307: 168-174.
91. Lu W, Tan YZ, Hu KL, Jiang XG (2005) Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm 295: 247-260.
92. Mahato RI, Narang AS, Thoma L, Miller DD (2003) Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 20: 153-214.
93. Mainardes RM, Silva LP (2004) Drug delivery systems: past, present, and future. Curr Drug Targets 5: 449-455.
94. Moghimi SM, Gray T (1997) A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. Clin Sci (Lond) 93: 371-379.
95. Moisan S, Marty JD, Cansell F, Aymonier C (2008) Preparation of functional hybrid palladium nanoparticles using supercritical fluids: a novel approach to detach the growth and functionalization steps. Chem Commun (Camb): 1428-1430.
96. Montasser I, Briancon S, Lieto J, Fessi H (2000) Methods of obtaining and formation mechanisms of polymer nanoparticles J Pharm Belg 55: 155-167.
97. Morishita M, Peppas NA (2006) Is the oral route possible for peptide and protein drug delivery? Drug Discov Tod 11: 905-910.
98. Na K, Lee ES, Bae YH (2003) Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J Control Release 87: 3-13.
99. Nishikawa T, Aklyoshi K, Sunamotto J (1996) Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticles of hydrophobized polysaccharides. J Am Chem Soc 118: 6110-6115.
100. Opanasopit P, Ngawhirunpat T, Rojanarata T, Choochottiros C, Chirachanchai S (2007) Camptothecin-incorporating N-phthaloylchitosan-g-mPEG self-assembly micellar system: Effect of degree of deacetylation. Col Surf B Bioint 60: 117-124.
101. Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, Hao JS, Cui FD (2002a) Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249: 139-147.
102. Pan Y, Zheng J-M, Zhao H-Y, LIi Y-J, Xu H, Wei G (2002b) Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres. Acta Pharmacol Sin 23: 1051-1056.
103. Passirani C, Barratt G, Devissaguet JP, Labarre D (1998) Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci 62: 775-785.
104. Petri B, Bootz A, Khalansky A, Hekmatara T, Muller R, Uhl R, Kreuter J, Gelperina S (2007) Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release 117: 51-58.
105. Pinto-Alphandary H, Aboubakar M, Jaillard D, Couvreur P, Vauthier C (2003) Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats. Pharm Res 20: 1071-1084.
106. Prego C, Torres D, Alonso MJ (2006) Chitosan Nanocapsules as Carriers for Oral Peptide Delivery: Effect of Chitosan MolecularWeight and Type of Salt on the In Vitro Behaviour and In Vivo Effectiveness. J Nanosci Nanotechnol 6: 2921-2928.
107. Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH (2003) Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vis 9: 559-568.
108. Ramachandran R, Paul W, Sharma CP (2009) Synthesis and characterization of PEGylated calcium phosphate nanoparticles for oral insulin delivery. J Biomed Mater Res B Appl Biomater 88: 41-48.
109. Rawat M, Singh D, Saraf S (2008) Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme. Drug Dev Ind Pharm 34: 181-188.
110. Rawat M, Singh D, Saraf S, Saraf S (2006) Nanocarriers: Promising vehicle for bioactive drugs. Biol Pharm Bol 29: 1790-1798.
111. Reis CP, Neufeld R, Ribeiro A, Veiga F (2006) Nanoencapsulation i: Methods for preparation of drug loaded polymeric nanoparticles. Nanomedicine 2: 8-21.
112. Reverchon E, Adami R (2006) Nanomaterials and supercritical fluids. J Supercrit Fluids 37: 1-22.
113. Roland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM (2005) Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J Am Chem Soc 127: 10096-10100.
114. Salamat-Miller N, Johnston TP (2005) Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int J Pharm 294: 201-216.
115. Sandri G, Bonferoni MC, Rossi S, Ferrari F, Gibin S, Zambito Y, Di Colo G, Caramella C (2007) Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur J Pharm Biopharm 65: 68-77.
116. Sandri G, Poggi P, Bonferoni MC, Rossi S, Ferrari F, Caramella C (2006) Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan. J Pharm Pharmacol 58: 1327-1336.
117. Santander-Ortega MJ, Bastos-Gonzalez D, Ortega-Vinuesa JL (2007) Electrophoretic mobility and colloidal stability of PLGA particles coated with IgG. Col Surf B Bioint 60: 80-88.
118. Schwendeman S, Costantino HR, Gupta RK, Langer R (1997) Peptide, protein and vaccine delivery from implantable polymeric systems: Processes and challenges. in Controlled Drug Delivery: Challenges and Strategies. K Park, Editor, American Chemical Society:Washington D.C.: 229-267.
119. Segura S, Espuelas S, Renedo MJ, Irache JM (2005) Potential of Albumin Nanoparticles as Carriers for Interferon Gamma. Drug Devel Ind Pharm 31: 271-280.
120. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A (2004) Poly-epsiloncaprolactone microspheres and nanospheres: an overview. Int J Pharm 278: 1-23.
121. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70: 1-20.
122. Stahn R, ZeisigR(2000) Cell adhesion inhibition by glycoliposomes: effects of vesicle diameter and ligand density. Tumour Biol 21: 176-186.
123. Stella B, Arpicco S, Peracchia MT, Desmaele D, Hoebeke J, Renoir M, D'Angelo J, Cattel L, Couvreur P (2000) Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89: 1452-1464.
124. Tai YC, McGuire J, Neff JA (2008) Nisin antimicrobial activity and structural characteristics at hydrophobic surfaces coated with the PEO-PPO-PEO triblock surfactant Pluronic F108. J Colloid Interf Sci 322: 104-111.
125. Teeranachaideekul V, Junyaprasert VB, Souto EB, Muller RH(2008) Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm 354: 227-234.
126. Thirawong N, Thongborisute J,Takeuchi H, Sriamornsak P (2008) Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release 125: 236-245.
127. Tiyaboonchai W, Limpeanchob N (2007) Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 329: 142-149.
128. Tobio M, Sanchez A, Vila A, Soriano I, Evora C, Vila-Jato JL, Alonso MJ (2000) The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Col Suf B Bioint 18: 315-323.
129. Truong-Le VL,Walsh SM, Schweibert E, Mao H-Q, Guggino WB, August JT, Leong KW(1999) Gene Transfer byDNA-Gelatin Nanospheres. Arch Biochem Biophys 361: 47-56.
130. Tsai ML, Bai SW, Chen RH (2008) Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle. Carbohydr Polym 71: 448-457.
131. Vila A, Gill H, McCallion O, Alonso MJ (2004) Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 98: 231-244.
132. Vogel V, Lochmann D, Weyermann J, Mayer G, Tziatzios C, van den Broek JA, Haase W, Wouters D, Schubert US, Kreuter J (2005) Oligonucleotide-protamine- albumin nanoparticles: preparation, physical properties, and intracellular distribution. J Control Release 103: 99-111.
133. Weyermann J, Lochmann D, Georgens C, Zimmer A (2005) Albumin-protamine- oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. Eur J Pharm Biopharm 59: 431-438.
134. Xie Y-L, Lu W, Jiang X-G (2006) Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Behav Brain Res 173: 76-84.
135. Yang XD, Zhang QQ, Wang YS, Chen H, Zhang HZ, Gao FP, Liu LR (2008) Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: Synthesis; characterization; aggregation and methotrexate release in vitro. Col Surf B Bioint 61: 125-131.
136. Yoo HS, Park TG (2004) Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. J Pharm Sci 93: 488-495.
137. You JO, Peng CA (2004) Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol Symp 219: 147-153.
138. Yu H, Wang W, Chen X, Deng C, Jing X (2006) Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers. Biopolymers 83: 233-242.
139. Zahoor A, Sharma S, Khuller GK (2005) Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 26: 298-303.
140. Zhang YY, Yang Y, Tang KS, Hu X, Zou GL (2008) Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci 107: 891-897.
141. Zhi JF, Wang Y, Luo G (2005) Adsorption of diuretic furosemide onto chitosan nanoparticles prepared with a water-in-oil nanoemulsion system. React Funct Polym 65: 249-257.